AlphaFold predicted structure
NDUFA6 · P56556

Mean pLDDT
87.5/ 100
Confident
128 residues
Confidence breakdown
- Very high(≥ 90)66%
- Confident(70–90)22%
- Low(50–70)6%
- Very low(< 50)6%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
NADH:ubiquinone oxidoreductase subunit A6
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
DDG2P
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalMitochondrial disorder with complex I deficiency
BIALLELIC, autosomal or pseudoautosomalMitochondrial disorders
BIALLELIC, autosomal or pseudoautosomalPossible mitochondrial disorder - nuclear genes
BIALLELIC, autosomal or pseudoautosomalPaediatric or syndromic cardiomyopathy
BIALLELIC, autosomal or pseudoautosomalmitochondrial complex I deficiency, nuclear type 33
type 2 diabetes mellitus
mitochondrial complex I deficiency
diabetes mellitus
neurodegenerative disease
mitochondrial disease
Parkinson disease
multiple sclerosis
Alzheimer disease
lysosomal storage disease
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6
Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed to be not involved in catalysis. Required for proper complex I assembly (PubMed:30245030). Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone
NDUFA6 · P56556

Mean pLDDT
87.5/ 100
Confident
128 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0